Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Fidelity offers lower costs and steadier returns, while State Street targets smaller biotech companies with higher volatility ...

Comparing the Vanguard Health Care ETF (NYSEMKT:VHT) and iShares Biotechnology ETF (NASDAQ:IBB) involves weighing a broad, ...

Cathie Wood’s ARK Invest continued to reshuffle its healthcare portfolio Monday across its ETFs, selling heavily in Twist ...

TWST and TXG are ARKG’s largest holdings as of Oct.2, together accounting for 20.27% of the fund. ・10x launched Atera shipments and its Nvidia-powered Sentira analysis platform in September, expanding ...

VanEck Biotech ETF is a Buy, offering concentrated exposure to leading biotech firms entering a new growth cycle. BBH’s top holdings—Amgen, Gilead, and Vertex—drive capital appreciation through ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Scientists meticulously analyze complex data on a monitor ...

In addition to the reversion trade factors, the sector has benefited from the steady move down in interest rates in 2025. This has been a tailwind for higher beta areas of the small caps, like small ...

The investment seeks to provide long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of ...

Vanguard Health Care ETF offers a significantly lower expense ratio and higher dividend yield than iShares Biotechnology ETF. iShares' ETF has delivered stronger one-year total returns but carries ...

Following the sale, iShares Biotechnology ETF is comprised 2.67% of DAFNA Capital’s 13F reportable assets under management. Top five holdings after the filing: NASDAQ:RVMD: $48.15 million (11.3% of ...